Table 1 Clinical characteristics of TNBC and non-TNBC breast cancer patients
From: miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer
|  | Non-TNBC (n = 50) | TNBC (n = 50) | P-value |
|---|---|---|---|
Age (mean, s.d.) | 50.7 (12.5) | 56.4 (14.1) | 0.0346 |
Histological type | |||
 Grade 1, 2 | 28 | 12 | 0.0067 |
 Grade 3 | 15 | 25 |  |
 NA | 7 | 13 | |
Metastasis | Â | Â | 0.0309 |
 No | 49 | 42 |  |
 Yes | 1 | 8 |  |
Stage | Â | Â | n.s. |
 0, I, II | 44 | 40 |  |
 III, IV | 5 | 10 |  |
 NA | 1 | 0 | |
Bilateral | Â | Â | n.s. |
 No | 48 | 47 |  |
 Yes | 2 | 3 |  |
Histological type | Â | Â | n.s. |
 DCIS | 5 | 1 |  |
 IDC | 42 | 42 |  |
 Mixed (IDC + ILC) | 1 | 2 |  |
 Others | 2 | 5 |  |